Metropolis Healthcare Ltd. owns and operates medical laboratories. The company is headquartered in Mumbai, Maharashtra and currently employs 4,289 full-time employees. The company went IPO on 2019-04-15. The firm operates through the pathology services segment. The firm offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The firm also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The firm offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The firm has spread its footprint across 20 Indian states and over 220 cities.

Metropolis Dividends

542650.BO dividend metrics

Dividend per share

542650.BO dividend history